Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| TWG | Top Wealth Group | $4.04 | -$1.33 | -24.77% | 585.2K | $7.9M | $3.25$28.11 |
| GLXG | Galaxy Payroll Group | $2.20 | -$0.60 | -21.43% | 60.1K | $16M | $1.54$16.80 |
| ROCK | Gibraltar Industries | $45.63 | -$9.11 | -16.64% | 99K | $1.6B | $42.86$75.08 |
| POLA | Polar Power | $1.99 | -$0.38 | -16.02% | 815.2K | $6.3M | $1.31$5.75 |
| QDEL | QuidelOrtho | $27.78 | -$4.95 | -15.12% | 547.8K | $2.2B | $19.50$46.24 |
| NEGG | Newegg Commerce | $47.75 | -$7.57 | -13.68% | 106K | $1.1B | $3.32$137.84 |
| XRX | Xerox | $2.17 | -$0.34 | -13.55% | 101.5K | $321M | $2.10$9.91 |
| LHAI | Linkhome | $2.18 | -$0.30 | -11.94% | 658.2K | $40M | $1.90$22.33 |
| EVTV | Envirotech Vehicles | $3.26 | -$0.42 | -11.41% | 1.6M | $18M | $0.33$9.30 |
| LEGN | Legend Biotech | $20.87 | -$2.55 | -10.89% | 2M | $4.3B | $20.14$45.30 |
Related Articles
Featured Article
After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?
Alex Carchidi|May 1, 2023
Legend's cell therapy seems like it's a winner, but it might be priced in already.
2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
Patrick Bafuma|Apr 6, 2022
With trials aimed at increasing addressable markets in the coming years, Legend and Immunocore could reward investors.
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
Here's why our roundtable loves Legend Biotech, Heron Therapeutics, and Pieris Pharmaceuticals.
Advertisement
2 Upcoming FDA Approval Decisions That Investors Should Really Watch
Keith Speights and Brian Orelli, PhD|Oct 23, 2021
The FDA is scheduled to announce these two key approval decisions in late November.
September Sell-Off: Buy These Stocks While They're Down
Anders Bylund|Sep 22, 2021
Successful investors buy great stocks when everyone else is selling in a panic. These high-quality stocks are trading at a market-risk discount right now and you should take advantage of these generous buying windows.
Could Newegg Stock Blast Off Once Again?
Zhiyuan Sun|Jul 22, 2021
Meme stock tailwinds could only lift the popular computer hardware retailer so far for so long.
Does Newegg's Stock Price Match Its Prospects?
Zhiyuan Sun|Jul 16, 2021
This computer parts supplier has more going for it than meets the eye, but is it overvalued?
These 2 Big Nasdaq Winners Are Defying the Downturn Wednesday
Dan Caplinger|Jul 7, 2021
Pressure on major indexes isn't hurting all stocks.
Will This 2020 Biotech IPO Crush the Market This Year?
Patrick Bafuma|Jun 29, 2021
Legend Biotech's CAR-T therapy's trial results were amazing, and could earn the treatment FDA approval in 2021.
This High-Yield Dividend Stock Might Be in Trouble
Leo Sun|Jun 5, 2021
Xerox trades at a low valuation and pays a big dividend, but it faces tough secular headwinds.
